Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC by Catherine Daniel, MD, PhD, Celine Callens, PharmD, PhD, Samia Melaabi, MD, Ivan Bieche, PharmD, PhD, Nicolas Girard, MD, PhD

Get full text